StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD)

Equities research analysts at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of AEMD opened at $0.38 on Tuesday. The firm has a market cap of $5.27 million, a P/E ratio of -0.13 and a beta of 1.79. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.35. The firm’s 50 day moving average price is $0.40 and its two-hundred day moving average price is $0.42.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.